Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery
Polymers · 21.09.2023 · 15 (18) · 3849
DOI: 10.3390/polym15183849 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Polymers, online erschienen am 21.09.2023. Verfasst von Thiago Medeiros Zacaron und 9 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (Originalsprache)
The evolution of respiratory diseases represents a considerable public health challenge, as they are among the leading causes of death worldwide. In this sense, in addition to the high prevalence of diseases such as asthma, chronic obstructive pulmonary disease, pneumonia, cystic fibrosis, and lung cancer, emerging respiratory diseases, particularly those caused by members of the coronavirus family, have contributed to a significant number of deaths on a global scale over the last two decades. Therefore, several studies have been conducted to optimize the efficacy of treatments against these diseases, focusing on pulmonary drug delivery using nanomedicine. Thus, the development of nanocarriers has emerged as a promising alternative to overcome the limitations of conventional therapy, by increasing drug bioavailability at the target site and reducing unwanted side effects. In this context, nanoparticles composed of chitosan (CS) show advantages over other nanocarriers because chitosan possesses intrinsic biological properties, such as anti-inflammatory, antimicrobial, and mucoadhesive capacity. Moreover, CS nanoparticles have the potential to enhance drug stability, prolong the duration of action, improve drug targeting, control drug release, optimize dissolution of poorly soluble drugs, and increase cell membrane permeability of hydrophobic drugs. These properties could optimize the performance of the drug after its pulmonary administration. Therefore, this review aims to discuss the potential of chitosan nanoparticles for pulmonary drug delivery, highlighting how their biological properties can improve the treatment of pulmonary diseases, including their synergistic action with the encapsulated drug.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduate Program in Pharmaceutical Science, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil.
- Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil.
- Postgraduate Program in Dentistry, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil.
- Laboratory of Micro and Nanotechnology-Farmanguinhos, FIOCRUZ-Fundação Oswaldo Cruz, Rio de Janeiro 21040-361, Rio de Janeiro, Brazil.
ORCID-Profile: Thiago Medeiros Zacaron, Ana Carolina Morais Apolônio, Frederico Pittella, Helvécio Vinícius Antunes Rocha, Guilherme Diniz Tavares
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Zitieren
APA
Zacaron, T. M., Silva, M. L. S. E., Costa, M. P., Silva, D. M. E., Silva, A. C., Apolônio, A. C. M., Fabri, R. L., Pittella, F., Rocha, H. V. A., & Tavares, G. D. (2023). Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery. Polymers, 15(18), 3849. https://doi.org/10.3390/polym15183849
Vancouver
Zacaron TM, Silva MLSE, Costa MP, Silva DME, Silva AC, Apolônio ACM, et al. Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery. Polymers. 2023;15(18):3849. doi:10.3390/polym15183849
BibTeX
@article{Zacaron2023,
author = {Zacaron, Thiago Medeiros and Silva, Mariana Leite Simões E and Costa, Mirsiane Pascoal and Silva, Dominique Mesquita E and Silva, Allana Carvalho and Apolônio, Ana Carolina Morais and Fabri, Rodrigo Luiz and Pittella, Frederico and Rocha, Helvécio Vinícius Antunes and Tavares, Guilherme Diniz},
title = {Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery},
journal = {Polymers},
year = {2023},
volume = {15},
number = {18},
pages = {3849},
doi = {10.3390/polym15183849}
}
EUVIMED